InflaRx (IFRX) Accumulated Expenses (2017 - 2026)

InflaRx has disclosed Accumulated Expenses across 10 years of filings, most recently posting -$595072.5 for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at -$595072.5, up 58.1% year-over-year; the trailing twelve-month figure through Mar 2026 was -$595072.5 (up 58.1% YoY), and the FY2025 annual result was $1.4 million, down 38.57% from the prior year.
• Accumulated Expenses came in at -$595072.5 for Q1 2026 at InflaRx, down from $1.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $2.2 million in Q4 2024 to a low of -$1.4 million in Q1 2025.
• The 5-year median for Accumulated Expenses is -$448390.8 (2023), against an average of -$139525.9.
• Across the five-year window, Accumulated Expenses sank 1635.55% in 2022 and soared 590.06% in 2023, its largest moves.
• InflaRx's Accumulated Expenses stood at -$65320.3 in 2022, then jumped by 590.06% to $320111.5 in 2023, then jumped by 589.23% to $2.2 million in 2024, then tumbled by 38.57% to $1.4 million in 2025, then tumbled by 143.91% to -$595072.5 in 2026.
• The last three Accumulated Expenses figures came in at -$595072.5 (Q1 2026), $1.4 million (Q4 2025), and -$649617.0 (Q3 2025), per Business Quant data.